asulacrine has been researched along with Leukemia P388 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwell, GJ; Baguley, BC; Denny, WA; Finlay, GJ; Rewcastle, GW | 1 |
| Atwell, GJ; Baguley, BC; Denny, WA | 1 |
| Atwell, GJ; Baguley, BC; Denny, WA; Finlay, GJ; Rewcastle, GW; Twigden, SJ; Wilson, WR | 1 |
| Baguley, BC; Finlay, GJ; Wilson, WR | 1 |
| Baguley, BC; Ching, LM; Darkin, SJ; Lawson, PA; Ralph, RK; Schneider, E | 1 |
| Baguley, BC; Wilson, WR | 1 |
| Baguley, BC; Grimwade, CD; Kernohan, AR | 1 |
7 other study(ies) available for asulacrine and Leukemia P388
| Article | Year |
|---|---|
Potential antitumor agents. 47. 3'-Methylamino analogues of amsacrine with in vivo solid tumor activity.
Topics: Acridines; Aminoacridines; Amsacrine; Animals; Cell Line; Chemical Phenomena; Chemistry; Colonic Neoplasms; DNA; Humans; Leukemia L1210; Leukemia P388; Mice; Solubility; Structure-Activity Relationship | 1986 |
Potential antitumor agents. 40. Orally active 4,5-disubstituted derivatives of amsacrine.
Topics: Administration, Oral; Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; DNA; Female; Injections, Intraperitoneal; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred DBA | 1984 |
Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cattle; Cell Division; Cell Line; Cell Survival; Cricetinae; DNA; Drug Evaluation, Preclinical; Humans; Indicators and Reagents; Intercalating Agents; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mice; Mice, Inbred Strains; Thymus Gland | 1984 |
Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.
Topics: Aminacrine; Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Colony-Forming Units Assay; Intercalating Agents; Isomerism; Leukemia P388; Mice; Quinacrine; Topoisomerase II Inhibitors; Tumor Stem Cell Assay | 1989 |
Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II.
Topics: Acridines; Aminacrine; Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Neoplasm Proteins; Quinacrine; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1988 |
Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of amsacrine.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Line; Drug Evaluation, Preclinical; Female; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mice; Neoplasm Transplantation; Tumor Stem Cell Assay | 1987 |
Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Intraperitoneal; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred Strains | 1985 |